Anthony P. Adamis
Director, EyePoint Pharmaceuticals.
Companies
- Kalaris Therapeutics, Inc.Board member Mar 18, 2025 to now1
- EyePoint PharmaceuticalsBoard member Jun 27, 2022 to Jun 25, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- EyePoint Pharmaceuticals EYPT4,000 shares3$12.0K at $2.99Jun 23, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 23, 2024Exercised options 2,000 shares of EyePoint Pharmaceuticals3
- Jun 23, 2023Exercised options 2,000 shares of EyePoint Pharmaceuticals4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 26, 2023